A dual-targeting bio-liposomes nanodrug repair endothelial cell dysfunction and restore macrophage cholesterol flow homeostasis to treat early atherosclerosis
Abstract Hyperhomocysteinemia (HHy) can lead to vascular endothelial cell dysfunction, progressive inflammation and lipid metabolism disorder, which finally result in the onset and development of atherosclerosis, a major contributor to cardiovascular diseases. Given the complexity of pathological pr...
Saved in:
| Main Authors: | Qi Zhang, Shengchao Ma, Xue Kang, Yi Liu, Fei Ma, Feifei Yu, Xiaolan Luo, Guizhong Li, Yinju Hao, Huiping Zhang, Bin Liu, Yideng Jiang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-05-01
|
| Series: | Journal of Nanobiotechnology |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12951-025-03436-5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Biomimetic nanocomplexes loading with evolocumab and curcumin for synergistic anti-atherosclerosis therapy in ApoE−/− mice
by: Yi Liu, et al.
Published: (2025-06-01) -
Tissue specific role of ABCA1 in lung cholesterol homeostasis under high-cholesterol diet
by: Jian Ma, et al.
Published: (2025-07-01) -
Early effects of PCSK9 inhibitors: evolocumab versus alirocumab
by: Su-Hyun Bae, et al.
Published: (2025-03-01) -
The downregulation of hormone-sensitive lipase and dysregulation of cholesterol receptors/transporter affect testicular lipid homeostasis and function in HFD-induced oligoasthenospermia mice
by: Min Pan, et al.
Published: (2025-08-01) -
PCSK9 Inhibitors: Focus on Evolocumab and Its Impact on Atherosclerosis Progression
by: Maram H. Abduljabbar
Published: (2024-11-01)